News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
65,308 Results
Type
Article (3046)
Company Profile (9)
Press Release (62253)
Section
Business (20624)
Career Advice (60)
Deals (3313)
Drug Delivery (3)
Drug Development (10264)
Employer Resources (1)
FDA (1423)
Job Trends (1534)
News (33867)
Policy (2230)
Tag
Academia (238)
Accelerated approval (14)
Adcomms (4)
Allergies (29)
Alliances (2266)
ALS (40)
Alzheimer's disease (261)
Antibody-drug conjugate (ADC) (71)
Approvals (1578)
Artificial intelligence (42)
Autoimmune disease (51)
Automation (2)
Bankruptcy (8)
Best Places to Work (1574)
BIOSECURE Act (1)
Biosimilars (19)
Biotechnology (8)
Bladder cancer (43)
Brain cancer (9)
Breast cancer (178)
Cancer (1130)
Cardiovascular disease (96)
Career advice (45)
CAR-T (49)
CDC (1)
Cell therapy (114)
Cervical cancer (8)
Clinical research (9483)
Collaboration (171)
Compensation (31)
Complete response letters (9)
COVID-19 (275)
CRISPR (13)
C-suite (45)
Cystic fibrosis (27)
Data (1661)
Depression (42)
Dermatology (17)
Diabetes (88)
Diagnostics (661)
Digital health (5)
Diversity (1)
Drug discovery (29)
Drug pricing (15)
Duchenne muscular dystrophy (69)
Earnings (17912)
Editorial (5)
Employer resources (1)
Events (10494)
Executive appointments (36)
FDA (2190)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (154)
Gene editing (35)
Generative AI (4)
Gene therapy (128)
GLP-1 (133)
Government (243)
Grass and pollen (1)
Guidances (178)
Healthcare (1785)
HIV (6)
Huntington's disease (5)
IgA nephropathy (21)
Immunology and inflammation (30)
Immuno-oncology (13)
Indications (37)
Infectious disease (330)
Inflammatory bowel disease (33)
Influenza (31)
Intellectual property (29)
Interviews (12)
IPO (2476)
IRA (5)
Job creations (80)
Job search strategy (32)
JPM (7)
Labor market (3)
Layoffs (35)
Leadership (1)
Legal (301)
Liver cancer (19)
Longevity (4)
Lung cancer (162)
Lymphoma (102)
Manufacturing (54)
MASH (33)
Medical device (1472)
Medtech (1483)
Mergers & acquisitions (958)
Metabolic disorders (199)
mRNA (22)
Multiple sclerosis (36)
NASH (1)
Neurodegenerative disease (68)
Neuropsychiatric disorders (20)
Neuroscience (515)
NextGen: Class of 2026 (442)
Non-profit (195)
Now hiring (1)
Obesity (73)
Opinion (18)
Ovarian cancer (56)
Pain (37)
Pancreatic cancer (42)
Parkinson's disease (60)
Partnered (2)
Patents (41)
Patient recruitment (104)
Peanut (15)
People (2065)
Pharmaceutical (4)
Pharmacy benefit managers (1)
Phase 1 (3060)
Phase 2 (4204)
Phase 3 (3392)
Pipeline (1769)
Policy (20)
Postmarket research (275)
Preclinical (1112)
Press Release (3)
Prostate cancer (59)
Psychedelics (12)
Radiopharmaceuticals (57)
Rare diseases (159)
Real estate (202)
Recruiting (1)
Regulatory (2493)
Reports (4)
Research institute (157)
Resumes & cover letters (21)
Rett syndrome (11)
RSV (19)
Schizophrenia (36)
Series A (32)
Series B (14)
Service/supplier (2)
Sickle cell disease (17)
Special edition (2)
Spinal muscular atrophy (25)
Sponsored (7)
Startups (211)
Stomach cancer (3)
Supply chain (3)
Tariffs (1)
The Weekly (2)
Vaccines (134)
Venture capital (6)
Weight loss (44)
Women's health (18)
Worklife (1)
Date
Last 7 days (118)
Last 30 days (432)
Last 365 days (4760)
2026 (1227)
2025 (4758)
2024 (5201)
2023 (5797)
2022 (6235)
2021 (6258)
2020 (5359)
2019 (3841)
2018 (2860)
2017 (2608)
2016 (1823)
2015 (2274)
2014 (1666)
2013 (980)
2012 (1031)
2011 (1201)
2010 (1023)
Location
Africa (36)
Alabama (8)
Alaska (1)
Arizona (43)
Asia (4357)
Australia (578)
California (1692)
Canada (523)
China (207)
Colorado (58)
Connecticut (95)
Delaware (140)
Europe (9554)
Florida (255)
Georgia (61)
Idaho (2)
Illinois (202)
India (11)
Indiana (124)
Iowa (2)
Japan (134)
Kansas (4)
Kentucky (9)
Louisiana (13)
Maine (16)
Maryland (173)
Massachusetts (1285)
Michigan (33)
Minnesota (80)
Mississippi (3)
Missouri (22)
Montana (4)
Nebraska (1)
Nevada (20)
New Hampshire (16)
New Jersey (657)
New York (457)
North Carolina (197)
Northern California (899)
Ohio (46)
Oklahoma (3)
Oregon (4)
Pennsylvania (503)
Puerto Rico (4)
Rhode Island (2)
South America (62)
South Carolina (2)
Southern California (674)
Tennessee (14)
Texas (246)
United States (6546)
Utah (51)
Virginia (10)
Washington D.C. (5)
Washington State (160)
Wisconsin (18)
65,308 Results for "101".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vascarta Announces Positive Clinical Trial Results for Topical/Transdermal Curcumin Gel VAS-101 in Knee Osteoarthritis
April 2, 2026
·
4 min read
Press Releases
Glycomine Completes Enrollment in Global Phase 2b POLAR Study of GLM101 for the Treatment of PMM2-CDG
April 2, 2026
·
3 min read
Press Releases
Kaida BioPharma Announces Executive Leadership Team to Advance KAD-101, Built for the Ovarian Cancer Gap
March 20, 2026
·
3 min read
Press Releases
Piston Bio Announces FDA Alignment on PST-101 Development Program for Cancer-Related Apathy
March 10, 2026
·
2 min read
Press Releases
Voro Therapeutics to Present New Preclinical Data on PrimeBody™ Platform and VOR-101 at Upcoming AACR 2026 and AET Europe Conferences
April 2, 2026
·
2 min read
Press Releases
Diagens Biotechnology Raises US$101 Million in Hong Kong IPO; Shares More Than Double on First Day of Trading
March 31, 2026
·
3 min read
Press Releases
Alto Neuroscience Reports Topline Data from Phase 2 Proof-of-Concept Study of ALTO-101 and Highlights Pipeline Advancements
April 2, 2026
·
7 min read
Press Releases
Encoded Therapeutics Announces FDA Alignment, Initiation of Pivotal Study, and ASGCT Presidential Symposium Presentation of ETX101 in Dravet Syndrome
March 25, 2026
·
5 min read
Press Releases
Telix Resubmits NDA to U.S. FDA for TLX101-Px (Pixclara®) Brain Cancer Imaging Candidate
March 15, 2026
·
9 min read
Press Releases
Sydnexis Announces New Data from Phase 3 STAR Trial of SYD-101 Presented at 2026 AAPOS Annual Meeting
March 23, 2026
·
6 min read
1 of 6,531
Next
